Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
8
×
national blog main
boston blog main
san francisco blog main
san francisco top stories
national
national top stories
biotech
boston top stories
cancer
texas blog main
texas top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
clinical trials
blueprint medicines
checkpoint inhibitors
fda
keytruda
opdivo
stanford university
amy heimberer
andrew berens
antidepressant
arena pharmaceuticals
assurex health
What
cancer
8
×
medicine
8
×
drug
fda
genetic
new
treatment
announced
fight
patients
plans
risks
study
allison
alzheimer's
approval
approved
area
bad
based
bay
biopsy
blood
blueprint
brain
buildout
cancers
cas
case
cells
centers
chasing
close
company
countless
crispr
cut
deadly
deciphera
deeper
Language
unset
Current search:
xconomy.com
×
medicine
×
" life sciences "
×
cancer
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
4 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Nobel Medicine Prize Honors Cancer Immunotherapy Pioneers Allison & Honjo
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
6 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?